CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Enoxacin Sesquihydrate 100mg  | ≥99%

CSNpharm

Enoxacin Sesquihydrate is a broad-spectrum fluoroquinolone antibacterial agent used in the treatment of urinary tract infections and gonorrhea, working by inhibiting bacterial DNA gyrase and topoisomerase IV.

More Information Supplier Page

Enoxacin Sesquihydrate 25mg  | ≥99%

CSNpharm

Enoxacin Sesquihydrate is a broad-spectrum fluoroquinolone antibacterial agent used in the treatment of urinary tract infections and gonorrhea, working by inhibiting bacterial DNA gyrase and topoisomerase IV.

More Information Supplier Page

Entacapone 10mg  | ≥99%

CSNpharm

Entacapone is a specific, potent and peripherally acting catechol-O-methyltransferase (COMT) inhibitor with IC50 of 151 nM for PD treatment.

More Information Supplier Page

Entacapone 50mg  | ≥99%

CSNpharm

Entacapone is a specific, potent and peripherally acting catechol-O-methyltransferase (COMT) inhibitor with IC50 of 151 nM for PD treatment.

More Information Supplier Page

Entacapone 100mg  | ≥99%

CSNpharm

Entacapone is a specific, potent and peripherally acting catechol-O-methyltransferase (COMT) inhibitor with IC50 of 151 nM for PD treatment.

More Information Supplier Page

Entacapone 25mg  | ≥99%

CSNpharm

Entacapone is a specific, potent and peripherally acting catechol-O-methyltransferase (COMT) inhibitor with IC50 of 151 nM for PD treatment.

More Information Supplier Page

Entecavir 50mg  | ≥98%

CSNpharm

Entecavir is a guanosine analogue that inhibits reverse transcription, DNA replication and transcription in the viral replication process, and is a potent, orally-active and selective inhibitor of HBV with an EC50 of 3.75 nM in HepG2 cell.

More Information Supplier Page

Entecavir 100mg  | ≥98%

CSNpharm

Entecavir is a guanosine analogue that inhibits reverse transcription, DNA replication and transcription in the viral replication process, and is a potent, orally-active and selective inhibitor of HBV with an EC50 of 3.75 nM in HepG2 cell.

More Information Supplier Page

Entecavir 10mg  | ≥98%

CSNpharm

Entecavir is a guanosine analogue that inhibits reverse transcription, DNA replication and transcription in the viral replication process, and is a potent, orally-active and selective inhibitor of HBV with an EC50 of 3.75 nM in HepG2 cell.

More Information Supplier Page

Entecavir-9 100mg  | ≥96%

CSNpharm

3’,5’-Di-O-benzyl Entecavir is an intermediate in the preparation of the hepatitis B antiviral agent entecavir.

More Information Supplier Page

Enterodiol 100mg  | ≥98%

CSNpharm

Enterodiol is a mammalian lignan formed by the action of intestinal bacteria from plant lignan precursors present in the diet and is potential anti-cancer effect.

More Information Supplier Page

Enzastaurin 250mg  | ≥99%

CSNpharm

Enzastaurin is a potent PKCβ selective inhibitor with IC50 of 6 nM, 6- to 20-fold selectivity against PKCα, PKCγ and PKCε.

More Information Supplier Page

Enzastaurin 100mg  | ≥99%

CSNpharm

Enzastaurin is a potent PKCβ selective inhibitor with IC50 of 6 nM, 6- to 20-fold selectivity against PKCα, PKCγ and PKCε.

More Information Supplier Page

Enzastaurin 10mg  | ≥99%

CSNpharm

Enzastaurin is a potent PKCβ selective inhibitor with IC50 of 6 nM, 6- to 20-fold selectivity against PKCα, PKCγ and PKCε.

More Information Supplier Page

Enzastaurin 50mg  | ≥99%

CSNpharm

Enzastaurin is a potent PKCβ selective inhibitor with IC50 of 6 nM, 6- to 20-fold selectivity against PKCα, PKCγ and PKCε.

More Information Supplier Page

Enzastaurin 5mg  | ≥99%

CSNpharm

Enzastaurin is a potent PKCβ selective inhibitor with IC50 of 6 nM, 6- to 20-fold selectivity against PKCα, PKCγ and PKCε.

More Information Supplier Page

Epalrestat 100mg  | ≥98%

CSNpharm

Epalrestat is an aldose reductase inhibitor with IC50 of 72 nM, and used for the treatment of diabetic neuropathy.

More Information Supplier Page

Epalrestat 10mg  | ≥98%

CSNpharm

Epalrestat is an aldose reductase inhibitor with IC50 of 72 nM, and used for the treatment of diabetic neuropathy.

More Information Supplier Page

Epalrestat 50mg  | ≥98%

CSNpharm

Epalrestat is an aldose reductase inhibitor with IC50 of 72 nM, and used for the treatment of diabetic neuropathy.

More Information Supplier Page

Eperisone HCl 10mg  | ≥99%

CSNpharm

Eperisone HCl has very low bioavailability after oral administration in rats and extensively high oral clearance in humans. It undergoes extensive first-pass metabolism after oral administration in rats and humans because absorption of the drug is very high. The bioavailabilities in the intestine were 0.176 and 0.0879 at administration rates of 100 and 25 mg/h/kg, […]

More Information Supplier Page

Eperisone HCl 50mg  | ≥99%

CSNpharm

Eperisone HCl has very low bioavailability after oral administration in rats and extensively high oral clearance in humans. It undergoes extensive first-pass metabolism after oral administration in rats and humans because absorption of the drug is very high. The bioavailabilities in the intestine were 0.176 and 0.0879 at administration rates of 100 and 25 mg/h/kg, […]

More Information Supplier Page